ArticleBritish journal of cancer2026
Preclinical efficacy of a systemically-administered, second-generation STING agonist that promotes anti-tumour immunity in combination with radiotherapy.
Malin Pedersen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.